Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00943774 · ClinicalTrials.gov registry record

High Resolution Phenotyping in Healthy Humans

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
300
Enrollment target

NCT00943774: Completed study, sponsored by Mayo Clinic.

NCT00943774 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00943774 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
300 participants
Enrollment target

Study Summary

Baroreflex sensitivity is integral to blood pressure regulation, and varies among healthy, normotensive individuals. A reduced compensatory ability of baroreflex buffering in patients with carotid denervation results in blood pressure variability and an elevated blood pressure response to mental stress. Furthermore, 24-hour ambulatory blood pressure variability may also be a significant and independent risk determinant of cardiovascular disease. It remains unknown whether the degree of baroreflex sensitivity and ambulatory blood pressure variability are predictive of the pressor response to sympathoexcitatory stress in healthy humans. In this study the investigators propose a comprehensive evaluation of the relationships among the pressor and forearm vasodilator response to sympathoexcitation, ambulatory blood pressure variability, and baroreflex sensitivity in healthy normotensive subjects. Ultimately this study will provide preliminary data and protocol development for large-scale high resolution phenotyping in population-based trials aimed at determining the functional relevance of candidate gene variation in intermediate physiological traits pertinent to the pathogenesis of hypertension and cardiovascular disease.

Interventions

  • OTHER Physiological maneuvers

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2006-04
Est. Completion 2013-02

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT00943774

The ClinicalTrials.gov registry entry for NCT00943774 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Physiological maneuvers is the first listed.

NCT00943774 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00943774 about?

NCT00943774 is a clinical study titled "High Resolution Phenotyping in Healthy Humans". Baroreflex sensitivity is integral to blood pressure regulation, and varies among healthy, normotensive individuals. A reduced compensatory ability of baroreflex buffering in patients with carotid denervation results in blood pressure variability and an elevated blood pressure response to mental str...

What is the current status of trial NCT00943774?

This trial is currently completed. The enrollment target is 300 participants. The study started on 2006-04. Estimated completion is 2013-02.

What interventions are being tested in trial NCT00943774?

The interventions under investigation include: Physiological maneuvers (OTHER).

Who is sponsoring clinical trial NCT00943774?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.